Welch Center for Prevention, Epidemiology and Clinical Research, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
VESS16 - Trends in Rivaroxaban Use for Symptomatic Peripheral Artery Disease Before and After FDA Approval
Wednesday, June 10, 20263:57 PM - 4:05 PM ET
